Temozolomide
By selecting your device, the default minimum transfer time will be set.
Please Log In to transfer IC
Log In
Add to Complex
Primary Application
Imprint
For what
Immune and Lymphatic
Source
Allopathy
For whom
People
Temozolomide is the most widely used chemotherapeutic agent in the treatment of the most common form of brain cancer, called glioblastoma (GBM). Temozolomide is an alkylating agent. It causes excessive DNA methylation, which impairs DNA synthesis, and thus cell division and cell survival. As a powerful form of chemotherapy, it is strongly advised that no one other than those with a confirmed diagnosis of GBM use this IC.
Please select language
Select